Pharmabiz

Agilus Diagnostics launches Idylla system to deliver cancer mutation results in just 3 hours

Agilus Diagnostics launches Idylla system to deliver cancer mutation results in just 3 hours: Our Bureau, Mumbai Tuesday, ...
Pharmabiz

NIMHANS unveils PARICHAY device prototype for acute stroke intervention EVRI Lab funded by SERB/ANRF

NIMHANS unveils PARICHAY device prototype for acute stroke intervention EVRI Lab funded by SERB/ANRF: Our Bureau, Bengaluru ...
Pharmabiz

Pharmac South 2026 showcases manufacturing excellence; draws over 7,500 visitors in Chennai

Pharmac South 2026 showcases manufacturing excellence; draws over 7,500 visitors in Chennai: Peethaambaran Kunnathoor, ...
Pharmabiz

Barentz opens new pharma office in North America to strengthen local presence and partnership

Barentz opens new pharma office in North America to strengthen local presence and partnership: Hoofddorp, Netherlands Tuesday, June 9, 2026, 18:00 Hrs [IST] Barentz, a leading glo ...
Pharmabiz

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector: Paris Tuesday, June 9, 2026, 16:00 Hrs [IST] The Europe ...
Pharmabiz

Roche enters collaboration with Nurix Therapeutics to co-develop and co-commercialise bexobrutideg, a BTK degrader

Roche enters collaboration with Nurix Therapeutics to co-develop and co-commercialise bexobrutideg, a BTK degrader: Basel Tuesday, June 9, 2026, 14:00 Hrs [IST] Roche announced th ...
Pharmabiz

Novo Nordisk announces Wegovy tablets 25 mg have surpassed three million prescriptions in just over five months

Novo Nordisk announced Wegovy (semaglutide) tablets 25 mg have surpassed three million prescriptions in just over five months, establishing Wegovy pill as one of the strongest US pharmaceutical ...
Pharmabiz

Pfizer presents positive results from multiple phase 2b studies of GLP-1 RA, berobenatide at 86th Scientific Sessions of ADA

Pfizer presents positive results from multiple phase 2b studies of GLP-1 RA, berobenatide at 86th Scientific Sessions of ADA: New York Tuesday, June 9, 2026, 13:00 Hrs [IST] Pfize ...
Pharmabiz

Bayer announces global consumer health leadership changes to accelerate growth

Bayer announces global consumer health leadership changes to accelerate growth: Basel, Switzerland Tuesday, June 9, 2026, 15:00 Hrs [IST] Bayer announced leadership changes within ...
Pharmabiz

Alembic Pharma to acquire 45% stake in Canadian Venture

Alembic Pharmaceuticals Limited stated that it has executed a shareholders’ agreement along with Difgen Holdings LLC and Sukhad Juneja to invest in a newly incorporated Canadian Corporation. The ...
Pharmabiz

US FDA grants expanded indication approval for Pfizer’s Hympavzi to treat two additional haemophilia A or B patient populations with significant medical need

US FDA grants expanded indication approval for Pfizer’s Hympavzi to treat two additional haemophilia A or B patient populations with significant medical need: New York Tuesday, ...
Pharmabiz

ManipalCigna India Health Quotient highlights the ‘Health Debt Trap’ with financial stress and high medical costs

ManipalCigna India Health Quotient highlights the ‘Health Debt Trap’ with financial stress and high medical costs: Our Bureau, Bengaluru Tuesday, June 9, 2026, 11:45 Hrs [IST] ...